The short answer
Form Health is our top pick for serious clinical care. Score 7.6 of 10. Board-certified obesity-medicine physicians, the highest documented prior-authorization approval rate in our chart and a clinical workup that surfaces comorbidities your previous program missed. The trade-off is the 7-day intake timeline and $299 per month starting cost.
What to know first
Most GLP-1 telehealth programs are operationally optimized for speed and cost, not clinical depth. Async intake, light review, ship the script. That works fine for healthy patients without comorbidities who tolerated GLP-1 in a previous trial. For patients with complex metabolic disease, board-certified obesity medicine clinicians make a measurable difference: higher PA approval rates, better identification of comorbidities that count for insurance criteria, dose-adjustment expertise during titration. Obesity medicine is a recognized subspecialty (American Board of Obesity Medicine, ABOM certification) and the programs that staff ABOM-certified physicians are the ones we score highest on clinical depth.
What we considered
- Board-certified obesity-medicine physicians on staff (ABOM certification)
- Full metabolic workup at intake (labs, comorbidity assessment, CV risk)
- Prior authorization approval rate on Wegovy and Zepbound
- Step-therapy and appeal letter quality
- Coordinated care with primary care or endocrinology when needed
Some visit links earn us a commission.
Scores out of 10, equal-weighted across five dimensions. How we score
Top pick: Knownwell
Form Health's board-certified obesity-medicine physicians, highest documented PA approval rate and full intake workup make it the clinical-depth pick for serious GLP-1 patients. The cost and 7-day timeline are the trade-offs for ABOM-level care.
Read the full Knownwell review →
Why Knownwell won this category
Form Health employs board-certified obesity-medicine physicians, not general telehealth clinicians. The American Board of Obesity Medicine (ABOM) certification requires medical school, residency, three years of obesity-specific practice and passing the ABOM exam. There are fewer than 8,000 ABOM-certified physicians in the US. Form Health has the largest concentration of them practicing in telehealth.
The PA approval rate is the differentiator. Form Health's documented first-pass approval rate on Wegovy and Zepbound PAs is the highest in our chart, particularly on step-therapy cases (Cigna, UHC) and complex comorbidity documentation. ABOM-certified physicians know exactly which boxes the PA reviewer wants checked; they document the comorbidities, prior therapy failures and clinical justification in the visit notes in the language PA reviewers approve.
The clinical workup includes the things general telehealth skips. Full metabolic panel, lipid panel, A1C, TSH, vitamin D, occasionally fasting insulin or homeostatic insulin resistance assessment. Body composition where appropriate. Cardiovascular risk stratification. The visit takes longer than a 30-minute Hims intake, and the cost is higher, but the diagnostic yield is substantially better.
The trade-offs are real. Form Health's intake-to-first-script is 5 to 7 days, not 24 hours. The monthly cost is $299 if you're cash-pay (which is high for the category). Insurance billing offsets this if your plan covers GLP-1 weight loss. The program is best fit for patients who want the clinical depth and either have insurance or are willing to pay the cash-pay premium for ABOM-level care.
Who this pick isn't for
Form Health is not the right pick if you're a healthy first-time GLP-1 patient without comorbidities looking for the fastest cheapest path to a script. The clinical depth is overkill for that patient profile, and you're paying $120 more per month than Mochi or Henry for clinical thoroughness you don't currently need. For straightforward cash-pay compounded, Mochi or Henry are the right picks.
Form Health is also not the right pick if you specifically want speed. The 5 to 7 day intake timeline reflects the full workup. That is a feature for patients who need it and a bug for patients who don't. If you're a switcher with a documented dose history and just need a refill channel, Hims or Henry deliver faster without the diagnostic overhead.
And Form Health doesn't fit if you want the cheapest insured path. PlushCare is also in-network with major commercial plans, has lower membership fees and gets you to the PA submission within 24 hours. Form Health's clinical edge is on the PA letter quality and step-therapy cases; PlushCare wins on speed and cost for plain-vanilla PA submissions.
Runner-up: 9amHealth
Knownwell is the runner-up for patients who want full primary-care integration alongside obesity medicine, particularly those managing multiple chronic conditions where coordinated care matters more than single-condition specialization.
Read the full 9amHealth review →
Top 3 compared
| Program | Score | Starts from | Lock-in | Time to Rx |
|---|---|---|---|---|
| Knownwell | 6.9 | $149/mo | Month-to-month | 14 days |
| 9amHealth | 7.3 | $298/mo | Month-to-month | 5 days |
Other strong picks
Frequently asked questions
What is American Board of Obesity Medicine certification?
Does board certification actually change outcomes?
What's the labs panel I should expect?
How is Form Health different from a regular endocrinologist?
Do I need clinical depth if I'm just looking for refills?
What about the cost?
Will my primary care doctor coordinate with Form Health?
Sources
- American Board of Obesity Medicine: certification requirements
- Obesity Medicine Association: clinical practice guidelines
- Wilding JP, et al. STEP-1: semaglutide in overweight or obesity. NEJM 2021
- ACC/AHA guideline on the management of overweight and obesity in adults
Related
